LH Labcorp Holdings Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:06
Aug 04
Aug 04
A news wire reports a broad list of price target increases from multiple analysts across dozens.
A news wire reports a broad list of price target increases from multiple analysts across dozens of stocks, with no directional commentary from the account itself.
09:58
Aug 03
Aug 03
A news wire reports a broad list of price target increases from multiple banks across dozens.
A news wire reports a broad list of price target increases from multiple banks across dozens of stocks, with no explicit directional calls or personal market views expressed.
03:52
Aug 03
Aug 03
JPMorgan raises its price target on Labcorp to 360 dollars from 330 dollars.
JPMorgan raises its price target on Labcorp to 360 dollars from 330 dollars, reflecting a more positive outlook on the company.
18:45
Jul 30
Jul 30
Labcorp raised its full-year outlook after reporting second-quarter earnings that exceeded.
Labcorp raised its full-year outlook after reporting second-quarter earnings that exceeded analyst estimates, driven by strength in cancer tests and new genetic screenings.
13:00
Jul 30
Jul 30
Guidance raised for revenue and EPS, driven by strong organic growth in both diagnostics and BLS, with continued margin expansion.
HIGH
13:00
Apr 30
Apr 30
Management raised guidance for the year, citing strong volume growth and margin expansion across both segments, with a positive outlook on the specialty testing and partnership pipeline.
HIGH
08:30
Apr 21
Apr 21
Quest management noted that health plans are increasingly questioning paying hospital outreach labs 200-300% of the rates paid to independent labs, signaling a shift in pricing power away from hospital systems. — If health plans normalize rates, it could benefit Quest and LabCorp by reducing hospital competition on price, potentially accelerating hospital lab outsourcing.
MED
04:16
Feb 24
Feb 24
The trade is to go long LabCorp (LH) following a significant price target upgrade from Piper.
The trade is to go long LabCorp (LH) following a significant price target upgrade from Piper Sandler, suggesting professional analyst conviction in the stock's upside.
MED
04:04
Feb 18
Feb 18
A price target increase from JPMorgan suggests a positive revision to their valuation model.
A price target increase from JPMorgan suggests a positive revision to their valuation model and expected upside for the stock.
MED
14:00
Feb 17
Feb 17
Management conveys strong confidence with positive guidance for 2026, driven by organic growth, launchpad savings, and improved margins, albeit with some headwinds from PAMA delay and ACA expirations fully incorporated.
HIGH
About LH Analyst Coverage
Buzzberg tracks LH (Labcorp Holdings Inc.) across 4 sources. 0 bullish vs 0 bearish calls from 7 analysts. Sentiment: evenly split. 10 total trade ideas tracked. Latest voices: DeItaone, FirstSquawk, Bloomberg.